Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained

Europace

Volumn 14, Issue 3, 2012, Pages 402-409

  Davis, Sarah ^a   Westby, Maggie ^b   Pitcher, David ^c   Petkar, Sanjiv ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

^d HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cost effectiveness; Decision analytic model; Diagnostic test; Implantable loop recorder; Syncope; Transient loss of consciousness

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEART ARRHYTHMIA; HUMAN; IMPLANTABLE LOOP RECORDER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RECORDER; SENSITIVITY ANALYSIS; SYNCOPE; TRANSIENT LOSS OF CONSCIOUSNESS; UNCONSCIOUSNESS;

ARRHYTHMIAS, CARDIAC; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; MONITORING, AMBULATORY; QUALITY-ADJUSTED LIFE YEARS; UNCONSCIOUSNESS;

EID: 84857868923     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur343     Document Type: Article

References (20)

1. Westby M, Davis S, Bullock I, Miller P, Cooper P, Turnbull N et al. Transient Loss of Consciousness ('Blackouts') Management in Adults and Young People. London: National Clinical Guideline Centre for Acute and Chronic Conditions, Royal College of Physicians; 2010. http://guidance.nice.org.uk/CG109 (1 September 2011, date last accessed).
2. Crane SD. Risk stratification of patients with syncope in an accident and emergency department. Emerg Med J 2002;19:23-7. (Pubitemid 34092532)
3. Farwell DJ, Sulke AN. Does the use of a syncope diagnostic protocol improve the investigation and management of syncope? Heart 2004;90:52-8. (Pubitemid 38064544)
4. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30: 2631-71.
5. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: NICE; 2008.
6. National Horizon Scanning Centre. Reveal Plus (TM) Implantable Loop Recorders for the Investigation of Syncope and Other Events-Horizon Scanning Review. Birmingham, UK: National Horizon Scanning Centre; 2004.
7. PSSRU. Unit Cost of Health and Social Care 2008. Kent, UK: Personal Social Services Research Unit; 2008.
8. Department of Health. NHS Reference Costs 2007-08. London: Department of Health; 2009.
9. National Institute for Health and Clinical Excellence. Dual-chamber Pacemakers for Symptomatic Bradycardia due to Sick Sinus Syndrome and/or Atrioventricular Block: NICE Technology Appraisal 88. London: National Institute for Health and Clinical Excellence; 2005.
10. Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C et al. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. Health Technol Assess 2006;10: Iii-xi, 1.
11. Lopez-Jimenez F, Goldman L, Orav EJ, Ellenbogen K, Stambler B, Marinchak R et al. Health values before and after pacemaker implantation. Am Heart J 2002; 144:687-92.
12. Shaw DB, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome). BMJ 1980;280:139-41. (Pubitemid 10215108)
13. Shaw DB, Kekwick CA, Veale D, Gowers J, Whistance T. Survival in second degree atrioventricular block. Br Heart J 1985;53:587-93. (Pubitemid 15069658)
14. Alboni P, Menozzi C, Brignole M, Paparella N, Gaggioli G, Lolli G et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome : The THEOPACE study: A randomized controlled trial. Circulation 1997;96:260-6. (Pubitemid 27298430)
15. Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmaco Economics 2000;17:479-500. (Pubitemid 30398806)
16. Farwell DJ, Freemantle N, Sulke AN. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J 2004;25:1257-63. (Pubitemid 38891577)
17. Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J 2006;27:351-6. (Pubitemid 43100032)
18. Medical Services Advisory Committee. Implantable loop recorder for unexplained syncope-Assessment Report. Medical Services Advisory Committee, Department of Health and Ageing, Australian Government; November 2003.
19. Organisation for Economic Co-operation and Development (OECD) (2008). Purchasing Power Parities for GDP. Paris: OECD; 2008.
20. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling Wet al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J 2006;27:2232-9. (Pubitemid 44412839)